The Prenatal Testing & Newborn Screening Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Prenatal Testing & Newborn Screening Market?
The market size of the prenatal testing & newborn screening sector has expanded swiftly in the past few years. The market size is projected to increase from $6.24 billion in 2024 to $6.99 billion in 2025, with a compound annual growth rate (CAGR) of 12.0%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Prenatal Testing & Newborn Screening Industry?
The Prenatal Testing & Newborn Screening Global Market Report 2025 projects that by 2029, the market size will be $11.08 billion with a compound annual growth rate (CAGR) of 12.2%.
Download Your Free Sample of the 2025 Prenatal Testing & Newborn Screening Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Prenatal Testing & Newborn Screening Market?
The key drivers in the prenatal testing & newborn screening market are:
• Increasing adoption of genetic counseling in prenatal and newborn screening
• Technological advancements in the sector
• Growing trend of point-of-care testing
• Rise in the use of telehealth and remote monitoring services
Global Market Segmentation: Identifying Major Prenatal Testing & Newborn Screening Industry Segments
The prenatal testing & newborn screening market covered in this report is segmented –
1) By Diagnostic Type: Non-Invasive, Invasive
2) By Technology: Screening Technology, Diagnostic Technology
3) By End user: Hospitals, Diagnostic centers
Pre-order the 2025 Prenatal Testing & Newborn Screening Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Prenatal Testing & Newborn Screening Market?
The key trends in the prenatal testing & newborn screening market are:
• Non-invasive prenatal testing (NIPT) represents an emerging trend.
• The rise of preimplantation genetic testing (PGT) is shaping the market.
• The use of telemedicine consultations is an emerging trend.
• The growing trend of maternal blood testing and sickle cell screening is shaping the market.
Who Are the Top Competitors & Leading Players in the Prenatal Testing & Newborn Screening Market?
Major companies in the prenatal testing & newborn screening market are:
• PerkinElmer Inc.
• Laboratory Corporation of America Holdings (LabCorp)
• Natera Inc.
• Invitae Corporation
• Centogene AG
• Cradle Genomics Inc.
• Roche Diagnostics International AG
• Quest Diagnostics Incorporated
• Baebies Inc.
• Progenity Inc.
• Ravgen Inc.
• Strand Life Sciences Pvt. Ltd.
• Eurofins Scientific
• Illumina Inc.
• Agilent Technologies Inc.
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd.
• Bio-Rad Laboratories Inc.
• General Electric Company
• Siemens Healthineers AG
• BGI Group
• QIAGEN N.V.
• Veracyte Inc.
• NIPD Genetics
• Novacyt UK
• Ariosa Diagnostics Inc.
• Verinata Health Inc.
• Counsyl a Myriad Company
• GenPath Diagnostics
• Sonic Healthcare Limited
• Cepheid a Danaher Company
• Guardant Health Inc.
• Genetron Health (Beijing) Co. Ltd.
Regional Dominance: Which Area Leads the Global Prenatal Testing & Newborn Screening Market?
North America was the largest region in the prenatal testing & newborn screening market in 2023
